Company Attana AB

Equities

ATANA

SE0010547273

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
0.069 SEK -1.43% Intraday chart for Attana AB -4.17% -30.30%

Business Summary

Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.

Number of employees: 10

Sales per Business

SEK in Million2021Weight2022Weight Delta
Biosensors
100.0 %
2 100.0 % 8 100.0 % +371.40%

Sales per region

SEK in Million2021Weight2022Weight Delta
Sweden
100.0 %
2 100.0 % 8 100.0 % +371.40%

Managers

Managers TitleAgeSince
Chief Executive Officer - 23-09-17
Founder 54 01-12-31
Director of Finance/CFO - -
Chief Operating Officer - 21-01-31
Corporate Officer/Principal - 06-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 71 16-12-31
Chairman 61 15-09-30
Founder 54 01-12-31
Director/Board Member 58 21-05-06
Director/Board Member 60 17-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 272,657,759 168,764,212 ( 61.90 %) 0 61.90 %

Company contact information

Attana AB

Greta Arwidssons Vaeg, 21

114 19, Stockholm

+

http://www.attana.com
address Attana AB(ATANA)